All Stories

  1. Efficacy and safety of sofosbuvir&ledipasvir for treatment of hepatitis C genotype 4 infection

    Article • Infection and Drug Resistance, March 2018, Dove Medical Press

    sherief Abd-Elsalam, Samy Khodeir, Mohamed Fouad, Rehab Badawi

  2. sofosbuvir plus daclatasvir with or without ribavirin in genotype 4 hepatitis C virus infection

    Article • Infection and Drug Resistance, March 2018, Dove Medical Press

    sherief Abd-Elsalam, Mohamed Fouad

  3. Sofosbuvir Plus Daclatasvir in Treatment of Chronic Hepatitis C Genotype 4 Infection in a Cohort of Egyptian Patients: An Experiment the Size of Egyptian Village

    Article • International Journal of Hepatology, January 2018, Hindawi Publishing Corporation

    Mohamed Fouad, sherief Abd-Elsalam

  4. Sofosbuvir plus ribavirin with or without interferon for HCV

    Article • Infectious Disorders - Drug Targets, July 2017, Bentham Science Publishers

    sherief Abd-Elsalam, Mohamed Fouad

  5. Value of serum CA 19-9 in obstructive jaundice

    Article • Egyptian Liver Journal, July 2016, Wolters Kluwer Health

    Mohamed Fouad

  6. The effect of the degree of hepatitis C-related fibrosis on the responsiveness to pegylated interferon α-2a versus pegylated interferon α-2b

    Article • Egyptian Liver Journal, April 2016, Wolters Kluwer Health

    Mohamed Fouad